Common Side Effects of Sapropterin
Sapropterin (Kuvan), used to lower blood phenylalanine levels in phenylketonuria (PKU) patients, causes side effects in many users. Headaches affect about 26% of patients, pharyngolaryngeal pain 24%, nasal congestion 16%, and cough 10%. Gastrointestinal issues like diarrhea (13%) and abdominal pain (12%) are frequent. Other common ones include rhinitis (9%), rash (6%), and vomiting (5%) from clinical trials.[1][2]
Serious Side Effects and Risks
Rare but serious effects include hypersensitivity reactions like anaphylaxis, angioedema, or severe rash, occurring in under 1% but requiring immediate discontinuation. Some patients experience increased phenylalanine levels, worsening PKU symptoms. Long-term use links to hyperphenylalaninemia flares. Monitor blood phenylalanine weekly during initiation.[1][3]
Side Effects by Patient Group
Children under 4 show higher rates of vomiting (13%) and fever (10%) compared to adults. In trials with over 850 patients, 18% discontinued due to adverse events, mainly headache or gastrointestinal issues. Pregnant patients face unknown risks; animal studies suggest fetal harm at high doses.[2][4]
How Side Effects Compare to Placebo
In placebo-controlled trials, headaches were 3x more common with sapropterin (26% vs. 8%), diarrhea 4x (13% vs. 3%), and nasal congestion 2x (16% vs. 8%). Most resolve without stopping treatment.[1]
Managing and Reporting Side Effects
Start with low doses (5 mg/kg/day) and titrate to reduce issues. FDA recommends phenylalanine monitoring and avoiding in phenylalanine hydroxylase deficiency alone. Report severe symptoms to FDA MedWatch. No specific DrugPatentWatch data on side effects, but patents cover formulations through 2027.[1][5]
[1]: FDA Label - Kuvan (sapropterin dihydrochloride). https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021937s016lbl.pdf
[2]: Kuvan Clinical Trials Summary. https://www.kuvan.com/hcp/efficacy-safety
[3]: BioMarin Prescribing Information. https://www.bmrn.com/professionals/kuvan/
[4]: PKU Management Guidelines (side effects section). https://www.ncbi.nlm.nih.gov/books/NBK1504/
[5]: DrugPatentWatch - Sapropterin Patents. https://www.drugpatentwatch.com/p/tradename/KUVAN